Polygenic scores for cardiovascular risk factors improve estimation of clinical outcomes in CCB treatment compared to pharmacogenetic variants alone (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41397-024-00333-2
Publication URI: http://dx.doi.org/10.1038/s41397-024-00333-2
Type: Journal Article/Review
Parent Publication: The Pharmacogenomics Journal
Issue: 3